|
Market Closed -
Nasdaq Stockholm
17:00:00 23/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 1.792 SEK | +3.58% |
|
-2.18% | -9.04% |
| 09-03 | Irlab CEO Kristina Torfgaard to step down in 2027 | FW |
| 09-03 | Irlab CEO Kristina Torfgaard wants to step down | FW |
Stock exchange
Nasdaq Stockholm
IRLAB A 1.792 kr
+3.58%
1.41M
kr
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| IRLAB A | 1.792SEK | +3.58% | 1.41M kr | ||
Deutsche Boerse AG
| 6IRA | 0.1498EUR | -0.40% | 0 € |
Quotes 5-day view: IRLAB Therapeutics AB
Delayed Quote Nasdaq Stockholm
| 17/09/2026 | 18/09/2026 | 21/09/2026 | 22/09/2026 | 23/09/2026 | |
|---|---|---|---|---|---|
| Last | SEK 1.734 | SEK 1.726 | SEK 1.740 | SEK 1.730 | SEK 1.792 |
| Volume | 540,640 | 719,801 | 238,406 | 526,473 | 789,554 |
| Change | -3.34% | -0.46% | +0.81% | -0.57% | +3.58% |
| Opening | SEK 1.760 | SEK 1.734 | SEK 1.728 | SEK 1.740 | SEK 1.730 |
| High | SEK 1.828 | SEK 1.826 | SEK 1.790 | SEK 1.778 | SEK 1.826 |
| Low | SEK 1.718 | SEK 1.692 | SEK 1.700 | SEK 1.680 | SEK 1.722 |
Performance
| 1 day | +3.58% | ||
| 1 week | -2.18% | ||
| 1 month | +4.31% | ||
| 3 months | +44.98% | ||
| 6 months | +13.56% | ||
| Current year | -9.04% | ||
| 1 year | -41.05% | ||
| 3 years | -75.18% | ||
| 5 years | -96.05% |
Volumes
marketsDaily volume
789,554
Estimated daily volume
789,554
Avg. Volume 20 sessions
883,486
Daily volume ratio
0.89
Avg. Volume 20 sessions SEK
1,583,206.91
Avg. Volume 20 sessions USD
159,636.34
Record volume 1
4,292,354
Record volume 2
4,261,996
Record volume 3
3,636,833
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Market Cap (SEK)
258,636,591
Market Cap (USD)
26,098,783
Net sales (SEK)
57,462,000
Net sales (USD)
5,798,438
Number of employees
31
Sales / Employee (SEK)
1,853,613
Sales / Employee (USD)
187,046
Free-Float
83.4%
Free-Float capitalization (SEK)
123,202,824
Free-Float capitalization (USD)
12,432,285
Average Daily Capital Traded
0.61%
Indicators
Moving average 5 days
1.745
Moving average 20 days
1.778
Moving average 50 days
1.577
Moving average 100 days
1.42
Price spread / (MMA5)
-2.63%
Price spread / (MMA20)
-0.78%
Price spread / (MMA50)
-12.00%
Price spread / (MMA100)
-20.75%
STIM
RSI 9 days
45.61
RSI 14 days
52.08
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.58% | -2.18% | -41.05% | -75.18% | 26.1M | |
| -1.64% | +1.16% | +54.09% | +109.07% | 1,043B | |
| -0.01% | +0.71% | +52.44% | +67.71% | 649B | |
| -0.05% | +0.98% | +19.08% | +73.55% | 469B | |
| -0.25% | +0.72% | +33.97% | +45.63% | 355B | |
| +0.98% | +3.30% | +19.63% | +27.91% | 270B | |
| -1.91% | +2.59% | +8.09% | +12.53% | 262B | |
| -1.01% | +7.90% | +41.59% | +51.70% | 222B | |
| -0.85% | +2.50% | +32.32% | +101.80% | 189B | |
| -2.53% | -8.57% | -34.17% | -60.67% | 175B | |
| Average | +0.15% | +1.42% | +18.60% | +35.40% | 363.31B | |
| Weighted average by Cap. | +0.44% | +2.19% | +35.28% | +65.85% |
Historical Quotes: IRLAB Therapeutics AB
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
b5b4c214e342efb51e5857a.1tgeKqbyJxC8kf7IXqchsCP2rGdF_9H_LfvC2uzD0NQ.lZEpTtGjTF3l4ZmDc8YMymyA1RAEsrzMHc-KsKCcqb2Eqi9k4p0VeMb5jQ
| Date | Price | Volume | Total |
|---|---|---|---|
| 16:29:59 | 1.792 | 439 | 789,554 |
| 16:29:59 | 1.792 | 2,500 | 789,115 |
| 16:29:59 | 1.792 | 60 | 786,615 |
| 16:29:59 | 1.792 | 1 | 786,555 |
| 16:06:59 | 1.804 | 1,000 | 786,554 |
| 16:06:46 | 1.806 | 292 | 785,554 |
| 16:06:46 | 1.806 | 155 | 785,262 |
| 16:06:46 | 1.806 | 553 | 785,107 |
Price Extremes
| 1 week | 1.68 |  | 1.83 |
| 1 month | 1.6 | | 1.96 |
| Current year | 1.17 | | 2.14 |
| 1 year | 1.17 | | 3.08 |
| 3 years | 1.17 | | 20.2 |
| 5 years | 1.17 | | 51.5 |
| 10 years | 1.17 | | 110 |
Monthly variations
Annual variations
| 2026 | -9.04% | ||
| 2025 | -81.67% | ||
| 2024 | +43.33% | ||
| 2023 | -80.42% | ||
| 2022 | -12.95% | ||
| 2021 | +4.76% | ||
| 2020 | +14.75% | ||
| 2019 | -41.90% | ||
| 2018 | +120.28% | ||
| 2017 | +142.37% |
- Stock Market
- Stocks
- IRLAB A Stock
- Quotes IRLAB Therapeutics AB
Select your edition
All financial news and data tailored to specific country editions
